SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000655
Filing Date
2024-05-09
Accepted
2024-05-09 06:05:56
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zura-20240331x10q.htm   iXBRL 10-Q 1282872
2 EX-31.1 zura-20240331xex31d1.htm EX-31.1 11705
3 EX-31.2 zura-20240331xex31d2.htm EX-31.2 11711
4 EX-32.1 zura-20240331xex32d1.htm EX-32.1 5506
5 EX-32.2 zura-20240331xex32d2.htm EX-32.2 5524
  Complete submission text file 0001410578-24-000655.txt   6170050

Data Files

Seq Description Document Type Size
6 EX-101.SCH zura-20240331.xsd EX-101.SCH 60497
7 EX-101.CAL zura-20240331_cal.xml EX-101.CAL 31008
8 EX-101.DEF zura-20240331_def.xml EX-101.DEF 271168
9 EX-101.LAB zura-20240331_lab.xml EX-101.LAB 483422
10 EX-101.PRE zura-20240331_pre.xml EX-101.PRE 409640
71 EXTRACTED XBRL INSTANCE DOCUMENT zura-20240331x10q_htm.xml XML 826738
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40598 | Film No.: 24928350
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)